Clinical Trial Update: Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED) [Phase 2]

View source ↗

Summary

Phase 2 trial update on desloratadine with oxybutynin for seasonal allergic rhinitis and post-nasal drip has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-nasal Drip
• Seasonal Allergic Rhinitis

Drugs mentioned

• Desloratadine with oxybutynin

Snippet

Sponsor: Organon and Co | Conditions: Post-nasal Drip, Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED